Skip to content
  • Sunday, 26 July 2026
  • 4:33 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Scientists Uncover How Gene Fusion Droplets Drive Rare Kidney Cancer Progression and Potential New Therapeutic Targets
Stem Cell & Regenerative Medicine

Scientists Uncover How Gene Fusion Droplets Drive Rare Kidney Cancer Progression and Potential New Therapeutic Targets

Dwi Wanna Jul 15, 2026 0

In a significant breakthrough for oncology and molecular biology, a multidisciplinary team of investigators at the Johns Hopkins Kimmel Cancer…

Read More
Pharmaceutical R&D

Immunai and Boehringer Ingelheim Forge Strategic Alliance to Uncover Novel T-Cell Targets in Oncology and Autoimmune Diseases

Teuku Ryan Jun 27, 2026 0

Immunai, a leading artificial intelligence (AI) company specializing in immune system analysis, and Boehringer Ingelheim, a global biopharmaceutical giant, have…

Read More
Pharmaceutical R&D

Novartis and Antares Therapeutics Forge Landmark Oncology Collaboration to Tackle Undruggable Cancer Targets

Teuku Ryan Jun 24, 2026 0

In a significant move poised to accelerate the development of novel cancer therapies, Novartis has entered into a strategic collaboration…

Read More
Biotech & Genetic Research

Precision DNA Editing Targets Root Cause of Severe Childhood Epilepsy in Preclinical Study

Jia Lissa May 26, 2026 0

A groundbreaking preclinical study led by researchers at The Jackson Laboratory (JAX; ME, USA) has successfully utilized precision gene editing…

Read More
Biotech & Genetic Research

Precision DNA editing targets root cause of severe childhood epilepsy in a preclinical study.

Jia Lissa May 18, 2026 0

In a landmark preclinical study, researchers from The Jackson Laboratory (JAX; Bar Harbor, ME, USA), in collaboration with the Broad…

Read More
Stem Cell & Regenerative Medicine

Breakthrough Combination Therapy Targets Cellular Differentiation Blocks to Provide New Treatment Pathway for Acute Myelogenous Leukemia

Dwi Wanna May 17, 2026 0

In a significant advancement for hematological oncology, researchers from Ludwig Cancer Research have unveiled a novel therapeutic strategy aimed at…

Read More
Neuroscience & Brain Research

Innovative Gene Therapy Targets Chronic Pain Circuits Without Addiction Risk in Landmark Preclinical Study

Rifan Muazin Apr 21, 2026 0

In a significant advancement for neurobiology and pain management, researchers from the University of Pennsylvania, Stanford University, and Carnegie Mellon…

Read More
Pharmaceutical R&D

The World Health Organization Targets Urgent Antibiotic Development to Combat Evolving Drug Resistance

Teuku Ryan Mar 14, 2026 0

The World Health Organization (WHO) has taken a significant step in its ongoing battle against antimicrobial resistance (AMR) by publishing…

Read More
Democratizing AI: Fine-Tuning Language Models Locally on Apple Silicon with MLX Marks a Paradigm Shift for Developers5 Must-Know Python Concepts for Professional DevelopersNew Two-Component Dark Matter Model Provides Unified Solution to Galaxy Density and Gravitational Lensing ParadoxesNew Tool Shines Light on Hidden Protein Mystery
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ